๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Expression of 5-aminolevulinic acid synthase in recombinantEscherichia

โœ Scribed by Junqing Wang; Junhui Wu; Zhaoming Zhang

Book ID
106564087
Publisher
Springer
Year
2006
Tongue
English
Weight
320 KB
Volume
22
Category
Article
ISSN
1573-0972

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hemodynamic effects of 5-aminolevulinic
Hemodynamic effects of 5-aminolevulinic acid in humans
โœ Mark A. Herman; John Webber; David Fromm; David Kessel ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 517 KB

Endogenous protoporphyrin IX (PpIX), which results from the oral administration of 5-aminolevulinic acid (ALA), is being investigated for its efficacy as a photosensitizing agent for photodynamic therapy (PDT). Clinical use of ALA has been associated with only mild gastrointestinal side effects. The

Regulation of human liver ฮด-aminolevulin
Regulation of human liver ฮด-aminolevulinic acid synthase by bile acids
โœ Anne-Kathrin Peyer; Diana Jung; Markus Beer; Carmela Gnerre; Adrian Keogh; Debor ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 660 KB

Aminolevulinic acid synthase 1 (ALAS1) is the rate-limiting enzyme of heme synthesis in the liver and is highly regulated to adapt to the metabolic demand of the hepatocyte. In the present study, we describe human hepatic ALAS1 as a new direct target of the bile acid-activated nuclear receptor farne